Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Receives Consensus Rating of “Moderate Buy” from Analysts

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has been assigned a consensus rating of “Moderate Buy” from the eight research firms that are currently covering the company, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average 1-year target price among analysts that have covered the stock in the last year is $92.00.

Several analysts have weighed in on ACHC shares. TheStreet raised shares of Acadia Healthcare from a “c” rating to a “b-” rating in a research note on Monday, March 4th. Mizuho increased their target price on Acadia Healthcare from $77.00 to $84.00 and gave the company a “neutral” rating in a report on Wednesday, March 6th. Deutsche Bank Aktiengesellschaft raised Acadia Healthcare from a “sell” rating to a “hold” rating and set a $70.00 price target on the stock in a research note on Thursday. Stephens upgraded shares of Acadia Healthcare from an “equal weight” rating to an “overweight” rating and set a $92.00 target price on the stock in a report on Friday, January 5th. Finally, Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $90.00 target price on shares of Acadia Healthcare in a research note on Tuesday, March 5th.

Insiders Place Their Bets

In related news, Director Wade D. Miquelon sold 2,203 shares of the business’s stock in a transaction dated Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total transaction of $188,114.17. Following the transaction, the director now owns 46,074 shares in the company, valued at $3,934,258.86. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Company insiders own 2.80% of the company’s stock.

Institutional Investors Weigh In On Acadia Healthcare

Hedge funds have recently made changes to their positions in the company. New York State Teachers Retirement System lifted its position in Acadia Healthcare by 0.3% during the first quarter. New York State Teachers Retirement System now owns 76,054 shares of the company’s stock valued at $6,025,000 after buying an additional 200 shares during the period. Louisiana State Employees Retirement System lifted its position in Acadia Healthcare by 2.3% during the 1st quarter. Louisiana State Employees Retirement System now owns 26,500 shares of the company’s stock valued at $2,099,000 after acquiring an additional 600 shares during the period. Raymond James Financial Services Advisors Inc. lifted its position in Acadia Healthcare by 24.9% during the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 55,322 shares of the company’s stock valued at $4,383,000 after acquiring an additional 11,022 shares during the period. Raymond James & Associates grew its holdings in Acadia Healthcare by 20.0% in the first quarter. Raymond James & Associates now owns 117,560 shares of the company’s stock worth $9,313,000 after purchasing an additional 19,618 shares during the period. Finally, DB Fitzpatrick & Co Inc increased its stake in shares of Acadia Healthcare by 93.7% during the first quarter. DB Fitzpatrick & Co Inc now owns 13,763 shares of the company’s stock valued at $1,090,000 after purchasing an additional 6,659 shares in the last quarter.

Acadia Healthcare Price Performance

Shares of Acadia Healthcare stock opened at $73.59 on Friday. The firm has a market capitalization of $6.80 billion, a PE ratio of -294.35, a price-to-earnings-growth ratio of 2.17 and a beta of 1.31. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 0.48. Acadia Healthcare has a 12 month low of $66.49 and a 12 month high of $87.77. The business’s 50-day moving average price is $78.07 and its 200-day moving average price is $77.70.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Wednesday, February 28th. The company reported $0.85 EPS for the quarter, beating analysts’ consensus estimates of $0.80 by $0.05. The business had revenue of $742.80 million for the quarter, compared to analysts’ expectations of $727.60 million. Acadia Healthcare had a negative net margin of 0.74% and a positive return on equity of 11.21%. The business’s quarterly revenue was up 10.0% on a year-over-year basis. During the same period last year, the business earned $0.70 earnings per share. Sell-side analysts forecast that Acadia Healthcare will post 3.57 EPS for the current fiscal year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.